chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness in the arm; Tenderness; Hard to move my arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in the arm), TENDERNESS (Tenderness) and MOBILITY DECREASED (Hard to move my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness in the arm), TENDERNESS (Tenderness) and MOBILITY DECREASED (Hard to move my arm). At the time of the report, HYPOAESTHESIA (Numbness in the arm), TENDERNESS (Tenderness) and MOBILITY DECREASED (Hard to move my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided.   Reporter did not allow further contact
03/21/2009 started with cold & cough, gave TYLENOL for fever.  On 3/26/09 Baby was very irritable R side of body- hand & leg would jerk simultaneously every 1/2 hour.  Irritability & crying increased went to ER 3 27 09 gave given IV fluids and hosp. was told due to "shots"
Nausea; body chills; severe headache. Those I had for about 36 hours - for the severe end of them. I had to hold me head - and felt like I had blood vessels rupturing. I have had migraines before and never had anything like that. From scale to 1-10 it was an 18. I took the Tylenol and that helped the symptoms to ease somewhat.
I?m the daughter I don?t know with my 5 year old here screaming and grabbing this device if I hit the wrong button but I?m not a doctor or the administrator of the shot and her symptoms are still ongoing. Sorry she is sick mad can?t even see from being so dizzy and she?s so tired she can?t focus or stay awake so I?m her daughter trying to fill this out.
Developed difficulty taking a deep breath along with chest pain, along with a racing heart and my hands becoming cold and turning purple like blood is not circulating.  these events come and go and were never consistent in nature.  I received that second does on January 28th and became very sick for 2 days with flu like symptoms .    At this point I am still suffer from the symptoms I described first that come and go pretty much daily.
Redness and swelling at injection site/entire upper arm; Left swelling 2-3 times normal size of arm.  Fever, vomiting
HEART ATTACK; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included shellfish allergy, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: 05-MAY-2021) dose was not reported, 1 total, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced heart attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of heart attack was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: 20210429381-covid-19 vaccine ad26.cov2.s-Heart attack. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
This case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a female patient who received FLUARIX QUADRIVALENT (batch number 2A2KX, expiry date 15th June 2015). On 2nd October 2014, the patient received FLUARIX QUADRIVALENT. On an unknown date, an unknown time after receiving FLUARIX QUADRIVALENT, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.
08/10/09 - @ approximately 3:15 pm patient had vaccinations by 5:00 pm developed fever, aches, nausea, tired. At 6:15 throat felt sore. 8/11/09 - at 6:15 AM throat felt swollen (internally.), fever (no thermometer). 08/12/09 - went to Dr. - Test influenza, no throat culture - Temp 99., patient - still felt ache and couldn't swallow Ibuprofen.
pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form twice a day and NAPROXEN SODIUM (ALEVE) ongoing since an unknown date at a dose of 1 dosage form once a day. At the time of the report, VACCINATION SITE PAIN (pain at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
My 2nd dose of the Phizer Covid-19 vaccine was on June 21. Starting within 2 weeks after the vaccine I started noticing intermittent twitching in my chest. It may happen 5-10 times per day now. There is no pain, but it feels like my heart is experiencing an issue.
Vertigo, symptoms off and on when waking, looking down or to the side; Node on lungs; Unable to drive long distance by myself; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in left arm on 06Apr2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included hysterectomy in 1991 due to endometriosis, high MCV and MCH count at over 100 (as reported). The patient had no allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7534) via an unspecified route of administration in left arm on 16Mar2021 at 09:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation.  On 01May2021, the patient had experienced vertigo and a node on lungs which was revealed in a CT scan of her right abdomen. This scan was unrelated to COVID but the patient's doctor saw the node and ordered a CT scan of the patient's lung as a result which was pending. Vertigo symptoms were off and on when waking, looking down or to the side. Also occurred on other occasions. The patient was unable to drive long distance by herself and was not sure when it will happen. No therapeutic measures were taken as a result of adverse events. The patient underwent lab tests and procedures which included COVID-19 virus test (nasal swab) on 19Jul2021,  23Jul2021, and on 26Jul2021, all which tested negative.  Since the vaccination, the patient had been tested for COVID-19. The events had resulted in a visit to the doctors or other healthcare professional office/clinic visit.  The clinical outcome of the events, vertigo, node on lungs and unable to drive long distance by herself was not recovered at the time of report.
UNABLE TO HAVE NORMAL BOWEL MOVEMENTS. FECES COMES OUT AS HARD PAINFUL GOLF BALL SIZE OR MARBLE SIZE.  ONE DAY IT CAN BE JUST 1 LARGE GOLF BALL SIZE AND A FEW MARBLES.  ANOTHER DAY JUST 7 MARBLE SIZE CLUMPS. THIS MORNING AFTER DRINKING A LAXATIVE LAST NIGHT, FINALLY HAD LIQUID MOVEMENT WHICH HELPED RELEASE THE PAIN IN MY INTESTINES.  WHEN SITTING ON TOILET AND RELAXING IT FEELS LIKE I'M ABOUT TO HAVE A MOVEMENT, THEN THE LOWER PART OF INTESTINES SEIZE AND CONTRACT THUS NOT ALLOWING ME TO EVACUATE PROPERLY.
Patient received his vaccine and sat down for his 15 minute observation period.  After approx 5 min of sitting, staff noticed patient was sweating profusely.  patient skin pale and clammy, very sweaty.  Patient stated he felt dizzy and his vision was blurry and he felt like he was going to pass out.  staff used an ammonia inhalant under patient's nose.  Cool papertowels applied to head.  Patient's mask and jacket were removed.  Patient given cold beverage.  Patient declined to lie on the floor.  BP 110/82, pulse 76 and regular.  Breathing normal, non labored.   staff sat next to patient for 15 minutes until patient stated he no longer felt he had to pass out.  Patient sat for an additional 15 minutes.  After 40 minutes of sitting, patient's color of face was no longer pale, skin warm to touch, no longer clammy and sweaty. staff stood next to patient as he stood from sitting position. patient stated he felt fine, no dizziness. Patient stated he was fine to drive himself home and he was going to go home and rest.
lowered blood platelet count; slightly elevated Granulocytes & Lymphocytes; slightly elevated Granulocytes & Lymphocytes; This is a spontaneous report received from contactable reporter consumer or other non HCP. The reporter is the patient.  A 13 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jun2021 (Lot number: EW0217) at the age of 13 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose, Lot no was EW0127, vaccine location was left arm, Outcome was lasting a week to two weeks), administration date: 09Jun2021, when the patient was 13 years old, for Covid-19 Immunization, reaction(s): "swollen lymph nodes in neck and base of skull". The following information was reported: PLATELET COUNT DECREASED (non-serious) with onset 29Jul2021, outcome "recovering", described as "lowered blood platelet count"; GRANULOCYTES ABNORMAL (non-serious), LYMPHOCYTE COUNT INCREASED (non-serious) all with onset 29Jul2021, outcome "recovering" and all described as "slightly elevated Granulocytes & Lymphocytes". The events "lowered blood platelet count", "slightly elevated granulocytes & lymphocytes" and "slightly elevated granulocytes & lymphocytes" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of platelet count decreased, granulocytes abnormal, lymphocyte count increased.     Additional information:- The patient had no known allergies.Facility where the most recent COVID-19 vaccine was administered in pharmacy or Drug Store.Reported event that swollen lymph nodes in neck after dose 1 followed by swollen lymph nodes in neck and base of skull lasting a week to two weeks CBC conducted 29Jul2021 at pediatric office showed lowered blood platelet count (113) and slightly elevated Granulocytes & Lymphocytesthe patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. the patient did not received within 2 weeks of vaccination.Prior to vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, patient had not been tested for COVID-19.There was seriousness criteria.  No follow-up attempts are possible. No further information is expected.
Initial swelling and redness.  Next day redness and itching.  Within a week, blistering, bright red, severe itching, site spread four inches wide and like an arm band around my arm.
Approx 15 to 20 minutes of receiving vaccine - became SOB; The patient received the first dose of BNT162B2 on 08Mar2021 and the second dose on 22Jul2021; This is a spontaneous report from a contactable nurse. A 65-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly, administered in the left arm at a hospital, on 22Jul2021 09:45am (batch/lot number: ER8729) at 65 years old, as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history included asthma/factor 11 from an unknown date. The patient was not diagnosed with COVID-19 prior to vaccination and was not pregnant at the time of vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 intramuscularly on 08Mar2021 (batch/lot number: EN6203) at 65 years old, as DOSE 1, SINGLE for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the first dose of BNT162B2 on 08Mar2021 and the second dose on 22Jul2021. On 22Jul2021 10:15am (reported as approximately 15 to 20 minutes of receiving vaccine), the patient became SOB. The adverse event resulted in Emergency room/department or urgent care visit and patient received treatment. The outcome of the event SOB was not reported. Since the vaccination, the patient has not been tested for COVID-19.; Sender's Comments: Based on temporal association, a contributory role of BNT162B2 to the event SOB cannot be excluded. The case will be reassessed once more information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
p/vax pt awoke w/fever 102;severe body aching all over w/bad h/a;several hours later had nausea & vomiting;unable to keep anything down;required use of suppository for n/v control;cont to have temp, weak & h/a for several days after;
Extreme redness, warmth, itchiness, swelling, pain below injection site one week after first shot. Swelling spread to entire arm and turned into cellulitis - was given antibiotic to treat. Same reaction after second shot only 18 hours later. So far not quite as bad as the first but we?ll see as the week goes on.
Rt arm swollen, painful of pneumonia shot given on 6/30/11. Seen MD to for follow up 7/1/11. Pt had chills, nausea. Sx worse the next day 7/2/11 went to ER given KEFLEX.
patient experienced flu after taking the flu shot; Initial information was received on 12-Oct-2020 regarding an unsolicited non-valid non-serious case received from a consumer (patient) via social media.  This case involves a patient (unknown age and gender) who experienced flu (influenza), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
sick x9 days. C/O cough, decreased appetite, cough sob. sat 84%, fever 102.5. Acute resp failure hypoxia, COVID Pneumonia. Dexamethasone, ABX, and 3L O2. Overnight placed on AirVO 40L/50%. CPAP at night. remdisivir given. Wean AirVO to 30L35%. prior to discharge pt weaned to 3L NC. Walk study done, pt discharged with O2. Discharged with 4 more days of steroids.
3 hard dark red blisters appeared on my left foot. A week later they finally have busted and drying up.
Dose received: 3; Fever; Nausea; This is a spontaneous report from a non-contactable reporter (healthcare professional).  A 45-year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 12Jan2022 (Lot number: FD7218) at the age of 45 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine manufacture unknown (DOSE 1; MANUFACTURER UNKNOWN, Lot Number: UNKNOWN), for COVID-19 immunisation and Covid-19 vaccine manufacture unknown (DOSE 2; MANUFACTURER UNKNOWN, Lot Number: UNKNOWN), for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 12Jan2022, outcome "unknown", described as "Dose received: 3"; PYREXIA (non-serious) with onset an unknown date in Jan2022, outcome "unknown", described as "Fever"; NAUSEA (non-serious) with onset an unknown date in Jan2022, outcome "unknown", described as "Nausea".   No follow-up attempts are possible. No further information is expected.
My daughter had a mild seizure 5 minutes or less after receiving her first vaccine. She fell out of her chair, her eyes fluttered and rolled in the back of her head, her teeth were clocking and chattering and her body was shaking mildly. She lost consciousness for approximately 2 minutes. At 8:33 pm she felt a second seizure begin, her step father grabbed her before she could fall and again, her eyes fluttered and rolled in back of her head, her teeth were clicking and chattering and her whole body was shaking. The second episode lasted approximately 2 minutes as well, with her losing consciousness again. She was taken to the emergency room and stayed overnight for observation.
The day after the second dose of moderna Covid 19, pt developed scattered urticaria with pruritis to bl arms and legs, less concentrated to the trunk
FLU LIKE SIDE EFFECTS; SEVERE BODY ACHES; SEVERE CHILLS; MODERATE FEVER; SEVERE TENSION IN MY HEAD; SEVERE FATIGUE; This spontaneous report received from a patient concerned a 31 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, the batch number were not reported and has been requested) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On Mar-2021, the subject experienced flu like side effects, severe body aches, severe chills, moderate fever, severe tension in my head, and severe fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the flu like side effects, severe chills, moderate fever, severe body aches, severe tension in my head and severe fatigue was not reported. This report was non-serious.
10min p/vax c/o dizziness & nausea, BP 100/60, P68, sl feb & resp good, lips sl pale 1/2 later sx cont;VS monitored apple juice & cookies given & placed in supine position;father notified & will pick child up
This spontaneous report was received from a consumer (mother) refers to a 7 weeks and 2 days old male patient. On an unknown date in November 1998 the patient's mother was vaccinated with varicella virus vaccine live (manufacturer unknown) dose 1. The child was exposed to the suspect vaccine in utero when the mother was 5.5 months pregnant. On an unspecified date in 1998 the patient developed chicken pox in utero and was born with chicken pox on an unspecified date. On an unknown date in 1999 the patient passed away due to affixation/sudden infant death syndrome (SIDS) (death), when he was 7 weeks and 2 days old. The outcome of affixation/SIDS was reported as fatal. The outcome of drug exposure in utero, born with chicken pox and developed chicken pox in utero was unknown. The reporter considered developed chicken pox in utero, affixation/SIDS and born with chicken pox to be related to varicella virus vaccine live (manufacturer unknown). This case is linked to case # 1401USA014406, # 1401USA014557 and case # 1401USA014599 via parent-child link. Additional information has been requested.
Information has been received from a pharmacist referring to a patient of unknown age and unknown gender. Information of concurrent condition, medical history, and drug reactions/allergies was not provided. Concomitant medication included sterile diluent. On 06-FEB-2019, the patient was vaccinated with one dose of expired VARIVAX (injection, lot # M006157 with expiration date 05-FEB-2019, dose detail was not reported), subcutaneously for prophylaxis. The sterile diluent (lot #/ expiration date unknown) that was used to reconstitute the VARIVAX was not expired. No adverse effect reported.
Patient stated that his left arm was swollen extending down to elbow. He said it was red and a little streaky. It was not sore just swollen. I was unable to see the patients arm. I recommended that he seek medical treatment as soon as possible. He said that the day after the vaccination it was more swollen than the day he contacted me (10/19/2017). It was getting better but I still recommended he call his PCP or go see him before the weekend.
Had shingles vaccine but also bad case/ suspected vaccination failure; Shingles bad case on back and up rectum; Painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had shingles vaccine but also bad case/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles bad case on back and up rectum) and pain (Verbatim: Painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 23-MAR-2023 This case was reported by patient via interactive digital media. The patient reported that he or she received Shingles vaccine and experienced bad case of shingles on his or her back and up his or her rectum. The patient stated that the shingles are very painful and he or she was experienced shingles twice. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow up was not possible, as no contact details were available.